We are live on ! Find out more
GCL

Glazer Capital LLC Portfolio holdings

AUM $4.71B
1-Year Est. Return 81.93%
This Fund
S&P 500
This Quarter Est. Return
+4.3%
1 Year Est. Return
+81.93%
3 Year Est. Return
+319.13%
5 Year Est. Return
+526.52%
10 Year Est. Return
+4,797.43%
AUM
$3.86B
AUM Growth
-$1.59B
Cap. Flow
-$1.68B
Cap. Flow %
-43.43%
Top 10 Hldgs %
19.14%
Holding
821
New
112
Increased
267
Reduced
93
Closed
295
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TZPSU
326
DELISTED
TZP Strategies Acquisition Corp. Unit
TZPSU
$438K 0.01%
43,213
CLAA.U
327
DELISTED
Colonnade Acquisition Corp. II Units, each consisting of one Class A ordinary share and one-fifth of one redeemable warrant
CLAA.U
$435K 0.01%
43,425
FRXB
328
DELISTED
Forest Road Acquisition Corp. II
FRXB
$433K 0.01%
43,134
-267,228
-86% -$2.66M
CRZNU
329
DELISTED
Corazon Capital V838 Monoceros Corp Unit
CRZNU
$429K 0.01%
42,564
+10,000
+31% +$99.8K
TIOAU
330
DELISTED
Tio Tech A Units
TIOAU
$426K 0.01%
+42,394
New +$423K
ATEK
331
DELISTED
Athena Technology Acquisition Corp. II
ATEK
$410K 0.01%
40,761
-56,687
-58% -$565K
TCOA
332
DELISTED
Zalatoris Acquisition Corp.
TCOA
$405K 0.01%
+40,341
New +$401K
SVFAU
333
DELISTED
SVF Investment Corp. Unit
SVFAU
$403K 0.01%
39,902
+17,648
+79% +$177K
WPCB.U
334
DELISTED
Warburg Pincus Capital Corporation I-B Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
WPCB.U
$398K 0.01%
39,497
+28,763
+268% +$288K
IRRX
335
DELISTED
Integrated Rail and Resources Acquisition Corp.
IRRX
$397K 0.01%
38,992
-10,000
-20% -$101K
SHAP.U
336
DELISTED
Spree Acquisition Corp. 1 Limited Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
SHAP.U
$396K 0.01%
+38,782
New +$394K
BMAC
337
DELISTED
Black Mountain Acquisition Corp.
BMAC
$391K 0.01%
38,373
+400
+1% +$4.04K
PMGM
338
DELISTED
Priveterra Acquisition Corp. II Class A Common Stock
PMGM
$383K 0.01%
37,600
-1,473,563
-98% -$14.8M
BOCNU
339
DELISTED
Blue Ocean Acquisition Corp Unit
BOCNU
$374K 0.01%
36,638
+8,865
+32% +$89.9K
HWKZ
340
DELISTED
Hawks Acquisition Corp
HWKZ
$363K 0.01%
36,300
+16,448
+83% +$163K
ITAQ
341
DELISTED
Industrial Tech Acquisitions II, Inc. Class A Common Stock
ITAQ
$349K 0.01%
34,267
-63,451
-65% -$639K
CCAI
342
DELISTED
Cascadia Acquisition Corp. Class A Common Stock
CCAI
$344K 0.01%
34,294
+10,700
+45% +$106K
RCAC
343
DELISTED
Revelstone Capital Acquisition Corp. Class A Common Stock
RCAC
$342K 0.01%
+34,141
New +$340K
VMCAU
344
DELISTED
Valuence Merger Corp. I Unit
VMCAU
$338K 0.01%
32,491
+32,486
+649,720% +$336K
INTE
345
DELISTED
Integral Acquisition Corporation 1 Class A Common Stock
INTE
$310K 0.01%
+30,630
New +$307K
EOCW
346
DELISTED
Elliott Opportunity II Corp.
EOCW
$309K 0.01%
+30,671
New +$305K
TBSAU
347
DELISTED
TB SA Acquisition Corp Unit
TBSAU
$304K 0.01%
30,157
+20,057
+199% +$200K
SPKBU
348
DELISTED
Silver Spike Acquisition Corp II Units
SPKBU
$296K 0.01%
29,432
+26,932
+1,077% +$269K
ARYE
349
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
$286K 0.01%
28,323
+18,224
+180% +$181K
DRAYU
350
DELISTED
Macondray Capital Acquisition Corp. I Unit
DRAYU
$279K 0.01%
+28,261
New +$285K

Similar funds

Glazer Capital LLC's Q4 2022 Portfolio in Review

As of Q4 2022, Glazer Capital LLC held 821 positions worth $3.86B, down 29% from $5.46B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Glazer Capital LLC withdrew a net $1.68B in Q4 2022, closing 295 positions and reducing 93 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $187M position sold in full.

By sector, the portfolio is most concentrated in Financials at 69% of assets, up from 64% a quarter earlier, followed by Technology and Industrials.

Against the trend, Glazer Capital LLC opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $41M.

  • Glazer Capital LLC's largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 360,496 shares worth $41M.
  • Glazer Capital LLC added most to Jaws Mustang Acquisition Corp. in Q4 2022, an estimated $52.5M increase.
  • Glazer Capital LLC's biggest Q4 2022 reduction was Envoy Medical, cutting an estimated $34M.
  • Glazer Capital LLC fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $187M.
  • Glazer Capital LLC's ten largest holdings make up 19% of its $3.86B portfolio in Q4 2022.
  • Glazer Capital LLC opened 112 new positions and closed 295 in Q4 2022.
  • Glazer Capital LLC's portfolio value fell 29% quarter-over-quarter to $3.86B.

Based on Glazer Capital LLC's 13F filing for Q4 2022, filed 14 Feb 2023.